Fujian Aonong Biological Technology Group Incorporation Ltd
SSE:603363
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its Industry Average (28.4), the stock would be worth ¥-11.68 (444% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -8.2 | ¥3.39 |
0%
|
| Industry Average | 28.4 | ¥-11.68 |
-444%
|
| Country Average | 26.4 | ¥-10.86 |
-420%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
F
|
Fujian Aonong Biological Technology Group Incorporation Ltd
SSE:603363
|
8.8B CNY | -8.2 | 4.9 | |
| US |
A
|
Archer-Daniels-Midland Co
XETRA:ADM
|
31B EUR | 20.2 | 33.5 | |
| US |
|
Bunge Ltd
NYSE:BG
|
24.1B USD | 13.4 | 29.5 | |
| SG |
|
Wilmar International Ltd
SGX:F34
|
22.5B SGD | 28.9 | 12.4 | |
| CN |
|
Tongwei Co Ltd
SSE:600438
|
78.2B CNY | -10 | -8.3 | |
| MY |
S
|
Sime Darby Plantation Bhd
KLSE:SIMEPLT
|
42.9B MYR | -113.8 | 23.1 | |
| US |
|
Darling Ingredients Inc
NYSE:DAR
|
10.1B USD | 38.1 | 160.6 | |
| US |
|
Ingredion Inc
NYSE:INGR
|
7B USD | 15.9 | 9.6 | |
| MY |
|
IOI Corporation Bhd
KLSE:IOICORP
|
26.8B MYR | 39.1 | 16.8 | |
| MY |
K
|
Kuala Lumpur Kepong Bhd
KLSE:KLK
|
23.6B MYR | -395.2 | 24.1 | |
| CN |
|
New Hope Liuhe Co Ltd
SZSE:000876
|
39.3B CNY | -131.8 | 39.6 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 13.7 |
| Median | 26.4 |
| 70th Percentile | 52.8 |
| Max | 2 279 450.9 |
Other Multiples
Fujian Aonong Biological Technology Group Incorporation Ltd
Glance View
Fujian Aonong Biological Technology Group, Inc. Ltd. operates as an agricultural development company, which engages in the animal husbandry, trade of raw materials, and finance related services. The company is headquartered in Xiamen, Fujian and currently employs 12,386 full-time employees. The company went IPO on 2017-09-26. The firm's main products include pig ingredients, pig concentrates and pig premixes. The firm is also engaged in pig farming, veterinary drugs and raw materials trading business, as well as the provision of Pig OK pig farm management information system. The firm mainly provides bank financing support and other full-service support for downstream customers through the Pig OK platform. The firm mainly operates its business in domestic market.
